NextPharma Revenue and Competitors

UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NextPharma's estimated annual revenue is currently $185.7M per year.(i)
  • NextPharma's estimated revenue per employee is $201,000

Employee Data

  • NextPharma has 924 Employees.(i)
  • NextPharma grew their employee count by 6% last year.

NextPharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Product DevelopmentReveal Email/Phone
3
Head Proposals and Program ManagementReveal Email/Phone
4
Head Quality/Qualified PersonReveal Email/Phone
5
Head QualityReveal Email/Phone
6
VP QualityReveal Email/Phone
7
Head QA/Qualified PersonReveal Email/Phone
8
Head Quality ControlReveal Email/Phone
9
EVP Sales and MarketingReveal Email/Phone
10
Head, Analytical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is NextPharma?

SAY YES TO WHAT'S NEXT! \n\nYour partner for pharmaceutical development and manufacturing with fast, flexible and personalised solutions for worldwide markets. \n\nWe are one of the leading European contract manufacturers in the pharmaceutical, biotech and healthcare industries. For us, the most important step is always the next. Because speed drives us, fills our working world with dynamism and allows us to grow. Our best recipe for joint success: space for passion. Because we are sure: Where excellent service inspires, passion is the best medicine. \n\nWelcome to NextPharma\n\nIn our world, the next step is always the one that matters most. Because passion deserves to be given free rein. That’s why our winning formula for shared success is ‘room for passion.’ For more than 1,400 employees at our sites in Berlin, Bielefeld, Göttingen, Waltrop, Limay (France) and Tampere (Finland). \n\nNextPharma develops and produces a broad range of pharmaceutical dosage forms: \n• Solids (tablets, capsules, powders, controlled-release pellets) \n• Liquids (suspensions, syrups, solutions) \n• Semi-solids (creams, gels, ointments, suppositories) \n\nSpecial containment areas are available for: \n• Hormones (solid and semi-solid)\n• Narcotics (controlled substances) \n• Beta lactam antibiotics (solids, liquids, dry syrups) \n• and clinical trials services.\n\nCareer opportunities\n\nPassion meets prospects\n\nJoining NextPharma means taking the next step. A strong step forward. Because you will be adding prospects to your passion. With vision. Whether you are a school-leaver, an entry-level candidate, a specialist or an executive: the pharmaceutical, biotech and healthcare industries are full of challenges and future potential. And it’s a future that we at NextPharma want to shape. Together with you.\n\n#SPEED #PASSION #SERVICE

keywords:N/A

N/A

Total Funding

924

Number of Employees

$185.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NextPharma News

2022-04-19 - Pharmaceutical Products and CMO Market Size, Outlook And ...

... Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, Mylan (DPT Laboratories), Recipharm, NextPharma Technologies, Dishman, Aesica.

2022-04-19 - Contract Pharmaceutical Manufacturing Market Size, Outlook ...

... Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$426.9M924N/AN/A
#2
$75M9254%N/A
#3
$233.4M926N/AN/A
#4
$186.3M9276%N/A
#5
$233.9M9285%N/A